Organization
PromiSight
1 clinical trial
Clinical trial
Safety and Preliminary Efficacy of Two Dose Levels of HydroLenz as a Protectant for Vitrectomy-Induced Lens Opacities in Subjects Undergoing VitrectomyStatus: Not yet recruiting, Estimated PCD: 2025-01-01